Antengene Corporation announced its appointment of Mr. Donald Lung as Chief Financial Officer (CFO), effective June 8, 2020. Donald will report directly to Dr. Jay Mei, Chairman and CEO of Antengene. In this position, Donald will be responsible for corporate financial strategy development, risk management, financial reporting and investment activities, aiming to promote the long-term development of Antengene in the biopharmaceutical sector. In addition, he will play an important role in business development, M&A and initiatives in business operations.